Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 28, 2026

Electroporation of Craniofacial Mesenchyme
07:23

Electroporation of Craniofacial Mesenchyme

Published on: November 28, 2011

12.5K

Craniofacial Microsomia.

Craig Birgfeld1, Carrie Heike2

  • 1Pediatric Plastic and Craniofacial Surgery, Seattle Children's Hospital, 4800 Sand Point Way, M/S OB.9.520, PO Box 5371, Seattle, WA 98105, USA.

Clinics in Plastic Surgery
|March 11, 2019
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unilateral Cleft Lip: Primary Repair.

Oral and maxillofacial surgery clinics of North America·2026
Same author

Partners in African Cleft Training (PACT): Evolution of a Partnership Supporting Sustainable Interdisciplinary Cleft Team Care in Sub-Saharan Africa.

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association·2025
Same author

Facial Nerve Pathology in Children.

Oral and maxillofacial surgery clinics of North America·2024
Same author

Characterizing Speech Phenotype in Individuals With Craniofacial Microsomia: A Scoping Review.

American journal of speech-language pathology·2023
Same author

Characterising the speech phenotype in individuals with craniofacial microsomia: a scoping review protocol.

BMJ open·2023
Same author

Two-Center Review of Posterior Vault Expansion following a Staged or Expectant Treatment of Crouzon and Apert Craniosynostosis.

Plastic and reconstructive surgery·2023
Same journal

Lower-Extremity Reconstruction: Principles, Progress, and Perspectives.

Clinics in plastic surgery·2026
Same journal

Pediatric.

Clinics in plastic surgery·2026
Same journal

Lower Extremity Reconstruction in Acute Burns.

Clinics in plastic surgery·2026
Same journal

Chronic Lower Extremity Wounds: Updates on Lower Extremity Reconstruction in Clinics in Plastic Surgery.

Clinics in plastic surgery·2026
Same journal

Updates in Lower Extremity Reconstruction: Post Sarcoma.

Clinics in plastic surgery·2026
Same journal

Fillet Flaps for Lower Extremity Salvage.

Clinics in plastic surgery·2026
See all related articles

Craniofacial microsomia, a condition affecting facial development from embryonic pharyngeal arches, presents with varied symptoms impacting the jaw, ear, and facial nerves. This preferred term encompasses several related diagnoses, highlighting the need for clear diagnostic criteria.

Area of Science:

  • Medical Genetics
  • Developmental Biology
  • Otolaryngology

Background:

  • Patients with underdevelopment of facial features from the first and second pharyngeal arches are diagnosed using various terms.
  • Craniofacial microsomia (CFM) is the currently preferred diagnostic term for these conditions.
  • Existing terminology includes first and second branchial arch syndrome, otomandibular dysostosis, and oculoauriculovertebral syndrome.

Purpose of the Study:

  • To clarify the diagnostic landscape for conditions affecting facial development originating from the embryonic first and second pharyngeal arches.
  • To highlight the clinical significance and impact of craniofacial microsomia.

Main Methods:

  • Review of clinical terminology and diagnostic practices for first and second pharyngeal arch developmental anomalies.
Keywords:
Craniofacial microsomiaDistraction osteogenesisGoldenhar syndromeHemifacial microsomiaOculoauriculovertebral syndromeOrthognathic surgeryPhenotypic assessment tool – craniofacial microsomia (PAT-CFM)Virtual surgical planning

More Related Videos

Dissection of Zebrafish Craniofacial Tissues Upon Staining with Alcian Blue
05:57

Dissection of Zebrafish Craniofacial Tissues Upon Staining with Alcian Blue

Published on: September 12, 2025

1.1K
Assessing Signaling Properties of Ectodermal Epithelia During Craniofacial Development
09:25

Assessing Signaling Properties of Ectodermal Epithelia During Craniofacial Development

Published on: March 24, 2011

9.9K

Related Experiment Videos

Last Updated: Jan 28, 2026

Electroporation of Craniofacial Mesenchyme
07:23

Electroporation of Craniofacial Mesenchyme

Published on: November 28, 2011

12.5K
Dissection of Zebrafish Craniofacial Tissues Upon Staining with Alcian Blue
05:57

Dissection of Zebrafish Craniofacial Tissues Upon Staining with Alcian Blue

Published on: September 12, 2025

1.1K
Assessing Signaling Properties of Ectodermal Epithelia During Craniofacial Development
09:25

Assessing Signaling Properties of Ectodermal Epithelia During Craniofacial Development

Published on: March 24, 2011

9.9K
  • Analysis of the common clinical features associated with craniofacial microsomia.
  • Main Results:

    • Craniofacial microsomia has emerged as the preferred diagnostic term, unifying several previously distinct labels.
    • While specific diagnostic criteria for CFM are lacking, affected individuals commonly exhibit underdevelopment of the mandible, maxilla, ear, orbit, facial soft tissue, and/or facial nerve.
    • These developmental anomalies can lead to significant functional impairments.

    Conclusions:

    • Craniofacial microsomia is a unifying term for a spectrum of developmental anomalies affecting the first and second pharyngeal arches.
    • The underdevelopment of facial structures in CFM can result in feeding difficulties, airway compromise, hearing loss, altered facial movement, and aesthetic concerns.
    • Further research is needed to establish clear diagnostic criteria for craniofacial microsomia.